Mark E. Cermak is Director at CME GROUP INC. (CME). They have made 5 open-market trades across 1 company since 2007, most recently 2013-06-25.
CIK 0001341454
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CME | SELL | 2009-12-14 | 2009-12-16 | $333.11 | $333K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2009-05-07 | 2009-05-11 | $241.78 | $604K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2008-11-05 | 2008-11-06 | $300.11 | $270K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2008-11-04 | 2008-11-06 | $314.75 | $629K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2007-11-01 | 2007-11-05 | $661.74 | $265K | -5.2% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.